Medicare Enrolled

Dr. Mary Kovacik Eicher, M.D.

Neurology · Greensburg, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
540 SOUTH ST STE 301, Greensburg, PA 15601
7242615610
In practice since 2014 (12 years)
NPI: 1659799476 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kovacik Eicher from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kovacik Eicher? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kovacik Eicher

Dr. Mary Kovacik Eicher is a neurology specialist in Greensburg, PA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Kovacik Eicher performed 917 Medicare services across 632 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kovacik Eicher received a total of $22,498 from 13 pharmaceutical and/or device companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kovacik Eicher is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 12% volume in PA $22,498 industry payments

Medicare Practice Summary

Medicare Utilization ↗
917
Medicare services
Top 12% in PA for neurology
632
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~76 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
353 $83 $185
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
129 $116 $240
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
113 $73 $166
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $59 $125
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 57 $57 $140
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
47 $10 $40
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
35 $101 $340
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
31 $152 $484
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
27 $154 $424
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
22 $9 $20
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
16 $38 $127
New patient office visit, complex (60-74 min) 15 $125 $345
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
14 $133 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,498
Total received (2019-2024)
Avg $7,499/year across 3 years
Top 15% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
13
Companies
68
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,774 (96.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$724 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,227
2023
$247
2019
$23

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$21,774
ACADIA Pharmaceuticals Inc
$195
Genentech USA, Inc.
$56
PFIZER INC.
$48
Eisai Inc.
$39
ARGENX US, INC.
$26
Abbott Laboratories
$26
UCB, Inc.
$22
Amneal Pharmaceuticals LLC
$21
Teva Pharmaceuticals USA, Inc.
$20
Top 3 companies account for 99.1% of 2024 payments
All-time payments by company (2019-2024) ›
ABBVIE INC.
$21,828
ACADIA Pharmaceuticals Inc
$195
Eisai Inc.
$144
ARGENX US, INC.
$56
Genentech USA, Inc.
$56
PFIZER INC.
$48
Abbott Laboratories
$42
Boston Scientific Corporation
$26
Allergan Inc.
$23
UCB, Inc.
$22
Amneal Pharmaceuticals LLC
$21
Teva Pharmaceuticals USA, Inc.
$20
Ceribell, Inc.
$16
Top 3 companies account for 98.5% of all-time payments
Associated products mentioned in payments ›
Austedo XR · BOTOX · Ceribell Rapid Response EEG · INFINITY · Leqembi · NUPLAZID · NURTEC ODT · Ocrevus · QULIPTA · RYTARY · Rystiggo · UBRELVY · VYVGART · VYVGART HYTRULO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a neurology specialist in Greensburg?
Compare neurologists in the Greensburg area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
95
Per 100K population
26.9
County median income
$72,468
Nearest hospital
EXCELA HEALTH WESTMORELAND REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kovacik Eicher is a clinical cardiology specialist, with above-average Medicare volume (top 12% in PA), with speaking/promotional industry engagement in the top 15% of PA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kovacik Eicher experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kovacik Eicher performed 353 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kovacik Eicher receive payments from pharmaceutical companies?
Yes. Dr. Kovacik Eicher received a total of $22,498 from 13 companies across 68 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kovacik Eicher's costs compare to other neurologists in Greensburg?
Dr. Kovacik Eicher's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kovacik Eicher) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →